With significant upside potential, Sanofi (NASDAQ:SNY) secures a spot on our list of the 12 Best Widow and Orphan Stocks to ...

Remission of prediabetes can occur even without weight loss, protecting against type 2 diabetes in up to 22% of individuals.

OPINION - In my experience, waiting for affordable medications is a matter of life and death. Each day that goes by without ...

Sanofi plans to make insulin more affordable and accessible for all patients next year. The company has taken action to fix insulin prices at $35 ...

The government shutdown adds yet another source of stress for the nation’s already overburdened aviation system — including ...

The U.S. Food and Drug Administration removed the Risk Evaluation and Mitigation Strategies (REMS) program for Caprelsa ...

By helping employees develop healthier lifestyle habits, employers can see a reduction in cost while improving people's lives ...

This installment of “Dissertation Diaries” highlights Udathari Kumarasinghe, a fifth-year Ph.D. candidate in the Department ...

Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of ...

The Fourth UN High-level Meeting of the UN General Assembly on the Prevention and Control of Non-communicable Diseases (NCDs) ...

Awiqli® (insulin icodec) injection, if approved, has the potential to be the first once-weekly basal insulin treatment available in the US for adult type 2 diabetes In adults with type 2 diabetes ...